[HTML][HTML] Tratamiento del estado epiléptico, consenso de expertos. Asociación Colombiana de Neurología, Comité de Epilepsia

…, C Espinosa, A Martínez, J Moreno, C Tolosa… - Acta Neurológica …, 2019 - scielo.org.co
OBJETIVO: Construir una serie de sugerencias para el tratamiento del EE, como resultado
del consenso por común acuerdo de expertos en epilepsia, teniendo en cuenta el contexto …

[HTML][HTML] Covid 19: manifestaciones neurológicas

JP Vergara, C Tolosa - Acta Neurológica Colombiana, 2020 - scielo.org.co
La enfermedad por coronavirus 2019 (covid-19) puede ser clasificada en asintomática, leve,
moderada, grave y crítica de acuerdo con los síntomas respiratorios. En 36% de los casos …

Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients

E Casado, J Gratacos, C Tolosa, JM Martínez… - Annals of the …, 2006 - ard.bmj.com
Objectives: To evaluate the prevalence and incidence of antimalarial myopathy in patients
with rheumatic diseases treated with antimalarial drugs. Methods: Over a three year period, all …

Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients

…, J Font, R Cervera, A Lopez-Soto, C Tolosa… - The American journal of …, 1994 - Elsevier
purpose: To determine whether the features of the antiphospholipid syndrome (APS) are in
any way influenced by the presence or absence of systemic lupus erythematosus (SLE). We …

[PDF][PDF] Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

…, L Martínez, V Fonollosa, G Espinosa, C Tolosa… - The American Journal of …, 2014 - cell.com
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …

Early-versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients

…, L Sáez, MJ Castillo, JL Callejas, MT Camps, C Tolosa… - Medicine, 2014 - journals.lww.com
Peak age at onset of systemic sclerosis (SSc) is between 20 and 50 years, although SSc is
also described in both young and elderly patients. We conducted the present study to …

Clinical presentation and short-and long-term outcomes in patients with isolated distal deep vein thrombosis vs proximal deep vein thrombosis in the RIETE registry

…, B Suárez-Rodríguez, JM Suriñach, C Tolosa… - JAMA …, 2022 - jamanetwork.com
Importance Insufficient data exist about the clinical presentation, short-term, and long-term
outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in …

Discharge against medical advice at a general hospital in Catalonia

R Duñó, E Pousa, J Sans, C Tolosa, A Ruiz - General Hospital Psychiatry, 2003 - Elsevier
Some studies on discharge against medical advice (AMA) in general hospitals report a
prevalence between 0.7–7% with 11–42% of this population identified as psychiatric patients. To …

A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus

…, JM Sabio, C Tolosa… - Annals of the …, 2017 - ard.bmj.com
Objectives During the last years, genome-wide association studies (GWASs) have identified
a number of common genetic risk factors for rheumatoid arthritis (RA) and systemic lupus …

Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

…, V Fonollosa, M Vilardell, J Candell, C Tolosa… - Annals of the …, 1997 - ard.bmj.com
OBJECTIVE To identify survival prognostic factors and markers of morbidity among patients
with systemic sclerosis (SSc). PATIENTS AND METHODS The study included 72 patients …